Doxorubicinum

Doxorubicin; (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (IUPAC). PubChem CID 31703 (free base); hydrochloride salt CID 443939. CAS 23214-92-8. Formula C27H29NO11 (free base; the hydrochloride is C27H30ClNO11), MW approx. 543.5 g/mol. · Adriamycin (original brand name); Adriamycinum (Latinized homeopathic form); 14-hydroxydaunorubicin (14-hydroxy analogue of daunorubicin); Doxorubicin hydrochloride.

Modern MM

A modern drug (chemotherapy) remedy with NO formal proving. Any homeopathic sphere of action is inferred purely from doxorubicin's documented toxicology under the Law of Similars: principal affinities are the heart (cardiomyopathy), the blood/bone marrow, the hair/scalp, the mucous membranes of the mouth and gut, and the general vitality. Use is essentially clinical/isopathic (the agent that caused the disturbance given in potency), not symptom-picture prescribing.

Key symptoms

No proving keynotes exist. The characteristic indications are derived solely from doxorubicin's documented toxicology (Law of Similars): cumulative, dose-dependent cardiotoxicity (cardiomyopathy/congestive heart failure); marked hair loss (alopecia); bone-marrow suppression (anaemia, low white cells, bruising/bleeding); nausea, vomiting and painful inflammation/ulceration of the mouth and gut (mucositis/stomatitis); anorexia and weakness; red discolouration of the urine. In homeopathic practice these correspond to the spheres for which a potentised preparation might be considered in supportive/isopathic prescribing.

Worse (aggravation)

Not established. No proving-derived modalities exist for Doxorubicinum; aggravation/amelioration cannot be stated from a reliable homeopathic source and must not be fabricated.

Better (amelioration)

Not established. No proving-derived amelioration is on record.

Manohar V Nagaiah

Materia Medica of Modern Homeopathic Medicine · 2026

Adriamycin (original brand name); Adriamycinum (Latinized homeopathic form); 14-hydroxydaunorubicin (14-hydroxy analogue of daunorubicin); Doxorubicin hydrochloride.

Source & Nature

Doxorubicinum is the potentised form of doxorubicin (original brand name Adriamycin), an anthracycline antineoplastic antibiotic and one of the most widely used cytotoxic chemotherapy drugs. It was discovered at Farmitalia Research Laboratories in Milan from Streptomyces peucetius, a soil bacterium cultured from a sample taken near Castel del Monte; the brand name honours the Adriatic Sea. Chemically it is the 14-hydroxylated analogue of daunorubicin (C27H29NO11, MW approx. 543.5, CAS 23214-92-8, PubChem CID 31703); it is dispensed clinically as the water-soluble hydrochloride for intravenous use against breast cancer, lymphomas, leukaemias, bladder/uterine cancers and sarcomas.

Continue Modern MM in the app

Classical texts are in the public domain. Educational reference only — not medical advice.